Medtronic Inc., the world’s largest heart-device maker, will be “opportunistic” in seeking acquisitions of as much as $1 billion to restore sales growth, Chairman and Chief Executive Officer Bill Hawkins said. The company, based in Minneapolis, will focus on “tuck- in” acquisitions that fill holes in its business, Hawkins said. While the device maker won’t exclude larger deals if �… Read all

pSivida Corp says its licensee Alimera Sciences has been notified that the US FDA has granted Priority Review status for the New Drug Application filed for Iluvien for the treatment of diabetic macular edema.

FDA Priority Review status is given to therapies that offer major advances in treatment or provide a treatment where no adequate therapy exists. This status reduces the review time… Read all

Pharmaceutical company Pharmaxis (ASX listed as PXS) today announced it has finalised a strategic marketing and sales service agreement for the commercialisation of Bronchitol for cystic fibrosis in Europe. Ahead of anticipated regulatory approval for Bronchitol, Pharmaxis has signed a six year agreement with the hig… Read all